These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22192080)

  • 1. Volociximab in cancer.
    Almokadem S; Belani CP
    Expert Opin Biol Ther; 2012 Feb; 12(2):251-7. PubMed ID: 22192080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits.
    Bhaskar V; Fox M; Breinberg D; Wong MH; Wales PE; Rhodes S; DuBridge RB; Ramakrishnan V
    Invest New Drugs; 2008 Feb; 26(1):7-12. PubMed ID: 17786386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.
    Ramakrishnan V; Bhaskar V; Law DA; Wong MH; DuBridge RB; Breinberg D; O'Hara C; Powers DB; Liu G; Grove J; Hevezi P; Cass KM; Watson S; Evangelista F; Powers RA; Finck B; Wills M; Caras I; Fang Y; McDonald D; Johnson D; Murray R; Jeffry U
    J Exp Ther Oncol; 2006; 5(4):273-86. PubMed ID: 17024968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
    Bhaskar V; Zhang D; Fox M; Seto P; Wong MH; Wales PE; Powers D; Chao DT; Dubridge RB; Ramakrishnan V
    J Transl Med; 2007 Nov; 5():61. PubMed ID: 18042290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.
    Ricart AD; Tolcher AW; Liu G; Holen K; Schwartz G; Albertini M; Weiss G; Yazji S; Ng C; Wilding G
    Clin Cancer Res; 2008 Dec; 14(23):7924-9. PubMed ID: 19047123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.
    Ng CM; Bai S; Takimoto CH; Tang MT; Tolcher AW
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):207-17. PubMed ID: 19468731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.
    Bell-McGuinn KM; Matthews CM; Ho SN; Barve M; Gilbert L; Penson RT; Lengyel E; Palaparthy R; Gilder K; Vassos A; McAuliffe W; Weymer S; Barton J; Schilder RJ
    Gynecol Oncol; 2011 May; 121(2):273-9. PubMed ID: 21276608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.
    Kuwada SK
    Curr Opin Mol Ther; 2007 Feb; 9(1):92-8. PubMed ID: 17330407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol alters the interaction of glycosphingolipid GM3 with alpha5beta1 integrin and increases integrin-mediated cell adhesion to fibronectin.
    Gopalakrishna P; Rangaraj N; Pande G
    Exp Cell Res; 2004 Oct; 300(1):43-53. PubMed ID: 15383313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction.
    Ordonez C; Zhai AB; Camacho-Leal P; Demarte L; Fan MM; Stanners CP
    J Cell Physiol; 2007 Mar; 210(3):757-65. PubMed ID: 17167768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.
    Magnussen A; Kasman IM; Norberg S; Baluk P; Murray R; McDonald DM
    Cancer Res; 2005 Apr; 65(7):2712-21. PubMed ID: 15805270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.
    Stachurska A; Elbanowski J; Kowalczyńska HM
    Cell Biol Int; 2012 Oct; 36(10):883-92. PubMed ID: 22686483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults.
    Bajaj M; Heath EI
    Expert Opin Biol Ther; 2011 Nov; 11(11):1519-24. PubMed ID: 21877997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
    Ciardiello F; Tortora G
    Clin Cancer Res; 2001 Oct; 7(10):2958-70. PubMed ID: 11595683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A co-clustering model involving alpha5beta1 integrin for the biological effects of GPI-anchored human carcinoembryonic antigen (CEA).
    Camacho-Leal P; Zhai AB; Stanners CP
    J Cell Physiol; 2007 Jun; 211(3):791-802. PubMed ID: 17286276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of soluble fibronectin to integrin alpha5 beta1 - link to focal adhesion redistribution and contractile shape.
    Huveneers S; Truong H; Fässler R; Sonnenberg A; Danen EH
    J Cell Sci; 2008 Aug; 121(Pt 15):2452-62. PubMed ID: 18611961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustered integrin α5β1 ligand displays model fibronectin-mediated adhesion of human endometrial stromal cells.
    Li Z; Kreiner M; van der Walle CF; Mardon HJ
    Biochem Biophys Res Commun; 2011 Apr; 407(4):777-82. PubMed ID: 21443861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.